Affinage

PBX2

Pre-B-cell leukemia transcription factor 2 · UniProt P40425

Length
430 aa
Mass
45.9 kDa
Annotated
2026-06-10
26 papers in source corpus 18 papers cited in narrative 17 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 7/7 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

PBX2 is a TALE-class homeodomain transcription factor that functions as a DNA-binding cofactor, regulating target gene expression through combinatorial complexes with HOX and PREP1/MEIS partners (PMID:1682799, PMID:7568094, PMID:7577680, PMID:10082572). It binds DNA cooperatively with HOX proteins (including Hoxb-7, Hoxb-8, and HOXA9) in a manner that requires the HOX hexapeptide and its linker to the homeodomain (PMID:7568094, PMID:7577680), and forms higher-order trimeric complexes with HOXA9 and MEIS1 that co-localize in nuclear speckles (PMID:10082572). Dimerization with PREP1 stabilizes PBX2 by preventing its proteasomal degradation, thereby increasing its DNA-binding activity; retinoic acid induces PBX2 as a primary transcriptional response and further extends PBX2 protein half-life via increased MEIS association (PMID:12871956, PMID:15095411). Through these complexes PBX2 directly regulates transcription of target promoters, acting either as an activator (HOX11) or as a repressor that interferes with neighboring factor binding (UGT2B17, CCL2) (PMID:12054735, PMID:12065766, PMID:18480829). Genetic analysis in mice establishes that PBX2 is functionally redundant with PBX1: Pbx2-null mice are viable and normal, but compound loss with Pbx1 reveals essential roles in distal limb and axial skeletal patterning through hierarchical control of Hox, Polycomb, Shh, and Pax1/Pax9 gene expression (PMID:15169896, PMID:16672333, PMID:18691704). PBX2 phosphorylation is set by the antagonistic activities of GSK3 (kinase) and PP1 (phosphatase) downstream of mTORC1 (PMID:36477205). In cancer, HOX/PBX2 dimers drive pro-tumorigenic transcriptional programs in melanoma, gastric cancer, and other contexts (PMID:23400877, PMID:33535170, PMID:37272544).

Mechanistic history

Synthesis pass · year-by-year structured walk · 16 steps
  1. 1991 High

    Establishing that PBX2 is a distinct homeodomain protein closely related to PBX1 defined it as a candidate DNA-binding transcription factor and member of a multigene family.

    Evidence cDNA cloning, sequence analysis, and Northern blotting

    PMID:1682799

    Open questions at the time
    • Did not define DNA-binding partners or target genes
    • No functional or in vivo role established
  2. 1995 High

    Demonstrating cooperative DNA binding with HOX proteins answered how PBX2 achieves binding specificity and identified the HOX hexapeptide-linker as the docking determinant.

    Evidence EMSA and deletion mutagenesis of the HOX hexapeptide and linker in vitro

    PMID:7568094 PMID:7577680

    Open questions at the time
    • In vitro binding only; cellular target genes not identified
    • Did not address higher-order complex composition
  3. 1999 High

    Identifying trimeric PBX2-HOXA9-MEIS1 complexes in myeloid cells showed PBX2 operates within multimeric assemblies and that MEIS1 promotes complex formation independent of DNA.

    Evidence EMSA, reciprocal Co-IP from endogenous myeloid nuclear extracts, and immunofluorescence colocalization in nuclear speckles

    PMID:10082572

    Open questions at the time
    • Direct transcriptional targets of the trimeric complex not defined
    • Functional consequence in hematopoiesis not tested here
  4. 2002 Medium

    Linking PBX2-PREP1 complexes to specific promoters established PBX2 as both an activator and a repressor depending on context.

    Evidence Reporter assays, EMSA, and competition binding on HOX11 and UGT2B17 promoters

    PMID:12054735 PMID:12065766

    Open questions at the time
    • Single-lab functional reporter studies
    • Endogenous regulation not confirmed in vivo
  5. 2003 High

    Showing PREP1 stabilizes PBX2 against proteasomal degradation answered how PBX2 abundance and DNA-binding activity are controlled post-translationally.

    Evidence Cycloheximide chase, MG132 treatment, immunoblotting, and EMSA in stable transfectants

    PMID:12871956

    Open questions at the time
    • E3 ligase and degradation signal not identified
    • Mechanism by which dimerization shields PBX2 unresolved
  6. 2004 Medium

    Defining PBX2 as a primary retinoic-acid-inducible gene whose protein is stabilized by MEIS association connected PBX2 to RA signaling and reinforced the partner-dependent stability model.

    Evidence Northern blotting, protein stability and inhibitor assays in P19 cells

    PMID:15095411

    Open questions at the time
    • RARE in the PBX2 promoter not mapped
    • Single cell-model system
  7. 2004 High

    The Pbx2 knockout revealed functional redundancy with Pbx1, showing PBX2 alone is dispensable for development despite being the predominant high-MW Pbx isoform in bone marrow and thymus.

    Evidence Pbx2-null mice with histological and hematopoietic characterization and immunoblotting

    PMID:15169896

    Open questions at the time
    • Redundant partner identity inferred but not directly tested here
    • Tissue-specific roles masked by compensation
  8. 2006 High

    Compound Pbx1/Pbx2 mutants established an essential, dosage-sensitive role in distal limb patterning via hierarchical control of Hox spatial distribution and Shh in the ZPA.

    Evidence Compound loss-of-function mouse genetics with in situ hybridization

    PMID:16672333

    Open questions at the time
    • Direct PBX2 target promoters in limb mesoderm not identified
    • Separation of PBX1 vs PBX2 contributions limited
  9. 2008 High

    Extending the genetic analysis to axial skeleton showed Pbx1/Pbx2 control Polycomb, Hox, and Pax1/Pax9 expression, placing PBX upstream of vertebral identity programs.

    Evidence Compound genetic mutants with in situ hybridization and immunohistochemistry

    PMID:18691704

    Open questions at the time
    • Direct vs indirect regulation of Polycomb/Pax genes not distinguished
    • Binding sites not mapped
  10. 2008 Medium

    Allele-specific Prep1/Pbx2 binding at the CCL2 promoter demonstrated PBX2 can act as a basal repressor whose activity is sensitive to promoter polymorphism and inflammatory stimulation.

    Evidence EMSA, allele-specific binding, and reporter assays in astrocyte lines

    PMID:18480829

    Open questions at the time
    • Endogenous CCL2 regulation by PBX2 not confirmed
    • Single-lab study
  11. 2013 Medium

    Pharmacological disruption of HOXB7/PBX2 dimers in melanoma linked the complex to miR-221/222 transcription and survival, implicating PBX2 in tumor cell viability.

    Evidence HXR9 antagonist treatment, luciferase reporters, miRNA expression, and apoptosis assays

    PMID:23400877

    Open questions at the time
    • Relies on peptide inhibitor specificity
    • Direct PBX2 binding at miR-221/222 loci not shown
  12. 2015 Medium

    Identifying PBX2 as a miR-1915-3p target showed PBX2 levels are post-transcriptionally regulated and contribute to apoptosis control in lung cancer.

    Evidence 3'-UTR luciferase reporter and miRNA rescue experiments in lung cancer lines

    PMID:26572100

    Open questions at the time
    • Single study
    • Downstream transcriptional effectors of PBX2 in this context not defined
  13. 2021 Medium

    Demonstrating HOXA6-mediated stabilization of PBX2 driving gastric cancer metastasis reinforced the partner-dependent stability theme in a tumorigenic setting.

    Evidence Co-IP, knockdown/overexpression, migration/invasion assays, and orthotopic mouse model

    PMID:33535170

    Open questions at the time
    • Stabilization mechanism not molecularly resolved
    • Single-lab study
  14. 2021 Low

    PBX2 was placed upstream of a circTLK1/JAK-STAT axis in glioma, extending its transcriptional reach to non-coding RNA targets.

    Evidence ChIP/promoter binding, RNA pull-down, AGO2-RIP, reporters, and knockdown in glioma cells

    PMID:34721518

    Open questions at the time
    • Limited direct validation of PBX2 binding at the circTLK1 locus
    • Single-lab, inferred upstream role
  15. 2023 Medium

    Identifying GSK3 and PP1 as the antagonistic kinase/phosphatase acting downstream of mTORC1 defined a specific signaling input controlling PBX2 phosphorylation, uniquely among PBX members.

    Evidence Phosphoproteomics re-analysis with rapamycin, GSK3, and PP1 inhibition plus knockdowns and phospho-immunoblotting

    PMID:36477205

    Open questions at the time
    • Functional consequence of phosphorylation on PBX2 activity not established
    • Phosphosite-resolved effects on DNA binding/complex formation unknown
  16. 2023 Medium

    The HOXB9/PBX2 dimer was shown to transcriptionally activate CDK6 and drive G1 progression, connecting PBX2 to cell-cycle control in gastric cancer.

    Evidence Co-IP, ChIP, reporter assays, knockdown, and cell cycle analysis in gastric cancer lines

    PMID:37272544

    Open questions at the time
    • Single-lab study
    • Generality across cancers not tested

Open questions

Synthesis pass · forward-looking unresolved questions
  • How PBX2 phosphorylation status mechanistically alters its DNA binding, partner selection, or transcriptional output remains unresolved.
  • No phosphosite-to-function link established
  • Genome-wide PBX2 binding landscape not defined
  • Direct target gene catalog incomplete

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0140110 transcription regulator activity 4 GO:0003677 DNA binding 3
Localization
GO:0005634 nucleus 1
Pathway
R-HSA-74160 Gene expression (Transcription) 4 R-HSA-1266738 Developmental Biology 2
Partners
GSK3HOXA6HOXA9HOXB7HOXB9MEIS1PBX1PREP1
Complex memberships
PBX2-HOXA9-MEIS1 trimeric complexPBX2-PREP1 heterodimer

Evidence

Reading pass · 17 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1991 PBX2 encodes a homeodomain protein with 92% identity to PBX1 over a 266-amino acid region spanning and flanking the homeodomain; unlike PBX1 and PBX3, PBX2 mRNA is not alternatively spliced. cDNA cloning, sequence analysis, Northern blotting Molecular and cellular biology High 1682799
1995 PBX2 binds cooperatively to DNA with Hoxb-7 and Hoxb-8; the Hox hexapeptide and its linker to the homeodomain are required for this cooperative DNA binding with PBX1 and PBX2. Electrophoretic mobility shift assay (EMSA), in vitro DNA binding assays, deletion mutagenesis of hexapeptide and linker Proceedings of the National Academy of Sciences of the United States of America; Mechanisms of development High 7568094 7577680
1999 In myeloid cells, PBX2 forms trimeric complexes with HOXA9 and MEIS1; MEIS1 enhances HOXA9-PBX2 complex formation in the absence of DNA, and all three proteins co-immunoprecipitate from myeloid nuclear extracts and co-localize in nuclear speckles. EMSA, co-immunoprecipitation from cell extracts, nuclear fractionation, immunofluorescence colocalization Molecular and cellular biology High 10082572
2002 A PBX2-containing complex (also including PREP1) binds a specific regulatory element (PRE-1048) in the HOX11 promoter and activates HOX11 transcription in K562 cells, representing the first report of a homeobox gene regulated specifically by PBX2. Reporter gene assays, EMSA/DNA binding assays, promoter deletion analysis Biochemical and biophysical research communications Medium 12054735
2002 A PBX2-PREP1 heterodimer binds the UGT2B17 promoter Pbx site and interferes with HNF1α binding to an adjacent site, thereby down-regulating HNF1α-mediated transcriptional activation of UGT2B17. Gel shift assays (EMSA), promoter-reporter functional assays, competition binding experiments Molecular pharmacology Medium 12065766
2003 PREP1 overexpression stabilizes PBX2 protein by preventing its proteasomal degradation; dimerization with PREP1 protects PBX2 from proteasome-dependent decay, thereby increasing PBX2-PREP1 DNA binding activity. Cycloheximide chase assay, proteasome inhibitor (MG132) treatment, immunoblotting, DNA binding (EMSA) in stable transfectants The Journal of biological chemistry High 12871956
2004 Retinoic acid (RA) induces PBX2 mRNA as a primary response (not requiring new protein synthesis) in a RAR-dependent manner, and RA treatment extends the half-life of PBX2 protein, at least partly through increased association with MEIS proteins and decreased proteasomal degradation. Northern blotting, protein stability assay, cycloheximide and transcription inhibitor treatment, immunoblotting in P19 cells Journal of cellular biochemistry Medium 15095411
2004 Pbx2 is functionally redundant with Pbx1 in mouse development; Pbx2-null mice are viable and fertile with no detectable developmental abnormalities, but Pbx2 is the predominant high-MW Pbx isoform in postnatal bone marrow and thymus. Genetic knockout (Pbx2−/− mice), immunoblotting, histological and hematopoietic analysis Molecular and cellular biology High 15169896
2006 Pbx1 and Pbx2 are co-expressed in lateral plate and early limb field mesoderm; compound loss-of-function (Pbx1−/−; Pbx2+/−) reveals that Pbx1/Pbx2 are required for distal limb patterning via hierarchical control of Hox gene spatial distribution and Shh expression in the ZPA. Genetic loss-of-function mouse model (compound mutants), in situ hybridization, gene expression analysis Development (Cambridge, England) High 16672333
2008 Pbx1/Pbx2 govern axial skeletal patterning by genetically controlling Polycomb and Hox expression/distribution in paraxial mesoderm and Pax1/Pax9 expression in sclerotome; decreasing Pbx2 dosage in Pbx1-null background severely worsens vertebral column identity loss. Compound genetic loss-of-function mouse model, in situ hybridization, immunohistochemistry Developmental biology High 18691704
2008 Prep1/Pbx2 complexes preferentially bind the -2578 G allele of the CCL2 promoter and suppress basal CCL2 transcription; upon IL-1β stimulation, the complex maintains binding but does not suppress inducible transcription, resulting in higher fold induction from G allele promoters. EMSA, promoter-reporter functional assays, allele-specific binding experiments in astrocyte cell lines Genes and immunity Medium 18480829
2013 The HOXB7/PBX2 dimer acts as a positive transcriptional regulator of miR-221 and miR-222 in melanoma; abrogation of HOXB7/PBX2 dimerization (using the HXR9 peptide antagonist) reduces miR-221/222 transcription and elevates c-FOS expression, leading to cell death. HOX/PBX dimerization antagonist (HXR9) treatment, luciferase reporter assays, miRNA expression analysis, apoptosis assays International journal of cancer Medium 23400877
2015 PBX2 is a direct post-transcriptional target of miR-1915-3p; miR-1915-3p binds the 3′-UTR of PBX2 mRNA, reduces PBX2 mRNA and protein levels, and knockdown of PBX2 contributes to the anti-apoptotic effect of miR-1915-3p in lung cancer cells. 3′-UTR luciferase reporter assay, miRNA overexpression/rescue experiments, immunoblotting in lung cancer cell lines Molecular medicine reports Medium 26572100
2021 HOXA6 physically interacts with PBX2 and stabilizes PBX2 protein in gastric cancer cells; co-expression of HOXA6 and PBX2 promotes migration and invasion in vitro and enhances metastasis in vivo. Co-immunoprecipitation, siRNA knockdown, overexpression, in vitro migration/invasion assays, orthotopic mouse model Aging Medium 33535170
2021 PBX2 transcriptionally activates circTLK1 expression in glioma cells, which in turn activates JAK/STAT signaling via the miR-452-5p/SSR1 axis to promote glioma progression. ChIP assay (or promoter binding), RNA pull-down, AGO2-RIP, luciferase reporter, knockdown experiments in glioma cells Frontiers in genetics Low 34721518
2023 PBX2, but not other PBX family members, is specifically dephosphorylated downstream of mTORC1 activity; GSK3 is the kinase responsible for PBX2 phosphorylation and PP1 is the phosphatase responsible for its dephosphorylation, with their antagonistic activities determining PBX2 phosphorylation status. Large-scale phosphoproteomics re-analysis, pharmacological inhibition of mTORC1 (rapamycin), GSK3, and PP1, gene knockdown experiments, immunoblotting with phospho-specific readout Journal of biochemistry Medium 36477205
2023 HOXB9 interacts with PBX2 to form a heterodimer that transcriptionally upregulates CDK6 in gastric cancer cells; this HOXB9/PBX2 complex drives G1-phase cell cycle progression and cytoskeletal organization downstream of E2F1. Co-immunoprecipitation, ChIP assay, reporter assays, siRNA knockdown, cell cycle analysis in gastric cancer cell lines The Journal of pathology Medium 37272544

Source papers

Stage 0 corpus · 26 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
1991 PBX2 and PBX3, new homeobox genes with extensive homology to the human proto-oncogene PBX1. Molecular and cellular biology 272 1682799
1994 Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3. Genomics 211 7835890
1999 HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells. Molecular and cellular biology 206 10082572
2006 Pbx1/Pbx2 requirement for distal limb patterning is mediated by the hierarchical control of Hox gene spatial distribution and Shh expression. Development (Cambridge, England) 154 16672333
1995 The hexapeptide LFPWMR in Hoxb-8 is required for cooperative DNA binding with Pbx1 and Pbx2 proteins. Proceedings of the National Academy of Sciences of the United States of America 98 7568094
1995 Hox gene products modulate the DNA binding activity of Pbx1 and Pbx2. Mechanisms of development 77 7577680
2004 The TALE homeodomain protein Pbx2 is not essential for development and long-term survival. Molecular and cellular biology 75 15169896
2016 Rice HOX12 Regulates Panicle Exsertion by Directly Modulating the Expression of ELONGATED UPPERMOST INTERNODE1. The Plant cell 74 26977084
2013 The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway. International journal of cancer 55 23400877
2004 Retinoic acid regulates the expression of PBX1, PBX2, and PBX3 in P19 cells both transcriptionally and post-translationally. Journal of cellular biochemistry 44 15095411
2003 Overexpression of PREP-1 in F9 teratocarcinoma cells leads to a functionally relevant increase of PBX-2 by preventing its degradation. The Journal of biological chemistry 39 12871956
2008 Pbx1/Pbx2 govern axial skeletal development by controlling Polycomb and Hox in mesoderm and Pax1/Pax9 in sclerotome. Developmental biology 38 18691704
2002 The homeodomain Pbx2-Prep1 complex modulates hepatocyte nuclear factor 1alpha-mediated activation of the UDP-glucuronosyltransferase 2B17 gene. Molecular pharmacology 24 12065766
2018 STAT6, PBX2, and PBRM1 Emerge as Predicted Regulators of 452 Differentially Expressed Genes Associated With Puberty in Brahman Heifers. Frontiers in genetics 21 29616079
2008 Prep1/Pbx2 complexes regulate CCL2 expression through the -2578 guanine polymorphism. Genes and immunity 20 18480829
2019 Ci-hox12 tail gradient precedes and participates in the control of the apoptotic-dependent tail regression during Ciona larva metamorphosis. Developmental biology 18 30819533
1995 The novel gene G17, located in the human major histocompatibility complex, encodes PBX2, a homeodomain-containing protein. Genomics 18 7759099
2021 Coexpression of HOXA6 and PBX2 promotes metastasis in gastric cancer. Aging 16 33535170
2023 The E2F1-HOXB9/PBX2-CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancer. The Journal of pathology 14 37272544
2015 MicroRNA‑1915‑3p prevents the apoptosis of lung cancer cells by downregulating DRG2 and PBX2. Molecular medicine reports 12 26572100
2021 Association of genomic variants at PAX8 and PBX2 with cervical cancer risk. International journal of cancer 11 33905146
2021 PBX2-Mediated circTLK1 Activates JAK/STAT Signaling to Promote Gliomagenesis via miR-452-5p/SSR1 Axis. Frontiers in genetics 10 34721518
2002 A complex containing PBX2 contributes to activation of the proto-oncogene HOX11. Biochemical and biophysical research communications 10 12054735
2016 Variant of PBX2 gene in the 6p21.3 asthma susceptibility locus is associated with allergic rhinitis in Chinese subjects. International forum of allergy & rhinology 6 26852910
2017 Microstructure variations induced by excess PbX2 or AX within perovskite thin films. Chemical communications (Cambridge, England) 4 29160311
2023 Phosphorylation of PBX2, a novel downstream target of mTORC1, is determined by GSK3 and PP1. Journal of biochemistry 1 36477205

Missed literature

Know a paper Affinage missed for PBX2? Flag it for the maintainers and the community.

No submissions yet.